The DOI matches its Crossref record.
Effects of Free Fatty Acids (FFA) on Glucose Metabolism: Significance for Insulin Resistance and Type 2 Diabetes
Abstract
Most obese individuals have elevated plasma levels of free fatty acids (FFA) which are known to cause peripheral (muscle) insulin resistance. They do this by inhibiting insulin-stimulated glucose uptake and glycogen synthesis. The mechanism involves intramyocellular accumulation of diacylglycerol and activation of protein kinase C. FFAs also cause hepatic insulin resistance. They do this by inhibiting insulin-mediated suppression of glycogenolysis. On the other hand, FFAs support between 30 and 50 % of basal insulin secretion and potentiate glucose-stimulated insulin secretion. The insulin stimulatory action of FFAs is responsible for the fact that the vast majority ( approximately 80 %) of obese insulin resistant people do not develop type 2 diabetes. They are able to compensate for their FFA mediated insulin resistance with increased FFA mediated insulin secretion. Individuals who are unable to do this (probably for genetic reasons) eventually develop type 2 diabetes. FFAs have recently been shown to activate the IkappaB/NFkappaB pathway which is involved in many inflammatory processes. Thus, elevated plasma levels of FFAs are not only a major cause of insulin resistance in skeletal muscle and liver but may, in addition, play a role in the pathogenesis of coronary artery disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity-related type 2 diabetes patients often have elevated plasma FFAs, because of either increased amounts of FFAs released from large amounts of adipose tissue or impaired FFA clearance [258].”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [258]
In the citing paper
“Alterations in non-esterified (i.e. free) fatty acid (NEFA) levels play a central role in the pathogenesis of insulin resistance and the development of metabolic diseases [8, 9].”
From Sleep restriction increases free fatty acids in healthy men (2015) · cites this paper as [9]
Citations
Cited by
Sorted by citations
Items 201–300 of 341
Zhang, Y., Yang, Z., Xu, Z., Wan, J., Hua, T., & Sun, Q. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2020-0083 · Cited by 13
Neonatal capsaicin causes compensatory adjustments to energy homeostasis in rats
van de Wall, E. H. E. M., Wielinga, P. Y., STRUBBE, J. H., & van Dijk, G. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.03.018 · Cited by 13
“A link between circulating FFAs and resistin is less clear, but correlation analysis in mice suggests an interaction between high circulating resistin levels with hyperlipidemia, as well as with obesity and insulin resistance [29].”
BackgroundInfluentialCoordinating Effect of VEGFC and Oleic Acid Participates to Tumor Lymphangiogenesis
Morfoisse, F., de Toni, F., Nigri, J., Hosseini, M., Zamora, A., Tatin, F., Pujol, F., Sarry, J., Langin, D., Lacazette, É., et al. (2021) · Cancers · doi:10.3390/cancers13122851 · Cited by 12
“FFA are well-known risk factors of cardiovascular diseases [16] and are closely related to the events of metabolic syndromes such as obesity and type 2 diabetes [17,18].”
BackgroundDong, W., Moon, S. J., Kelleher, J. K., & Stephanopoulos, G. N. (2019) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.9b05154 · Cited by 14
TLR2 and TLR4 activation induces p38 MAPK‐dependent phosphorylation of S6 kinase 1 in C2C12 myotubes
Zbinden‐Foncea, H., Deldicque, L., Pierre, N., Francaux, M., & Raymackers, J. (2012) · Cell Biology International · doi:10.1042/cbi20120081 · Cited by 12
“These two conditions are associated with both insulin resistance and proinflammatory cytokines production, the first situation being transitory whereas the second being chronic (Boden, 2003).”
BackgroundYang, Y., Lu, R., Gao, F., Zhang, J., & Liu, F. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11070 · Cited by 12
Salau, V. F., Erukainure, O. L., Koorbanally, N. A., & Islam, M. S. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13641 · Cited by 29
Umbayev, B. A., Saliev, T. M., Safarova, Y., Yermekova, A., Olzhayev, F., Bulanin, D. S., Tsoy, A., & Askarova, S. (2023) · Nutrients · doi:10.3390/nu15234964 · Cited by 15
Degerman, E., Manganiello, V., Holst, J. J., et al. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.096 · Cited by 11
Cai, M., Wan, J., Cai, K., Li, S., Du, X., Song, H., Sun, W., & Hu, J. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01490-x · Cited by 11
Quantitative proteomic analysis of murine white adipose tissue for peritoneal cancer metastasis
Feist, P. E., Loughran, E. A., Stack, M. S., & Hummon, A. B. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0813-9 · Cited by 10
Elevated Serum Triglycerides are Associated with Ketosis-Prone Type 2 Diabetes in Young Individuals
Ye, S., Ran, H., Zhang, H., Wu, H., Wen, L., Du, S., & Su, Q. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s296085 · Cited by 10
Winter is coming: Regulation of cellular metabolism by enzyme polymerization in dormancy and disease
Montrose, K., Cabezas, R. M. L., Paukštytė, J., & Saarikangas, J. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112383 · Cited by 9
Pouteau, E. B., Ferchaud‐Roucher, V., Zaïr, Y., Paintin, M., Enslen, M., Auriou, N., Macé, K., Godin, J., Ballèvre, O. P., & Krempf, M. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.05.006 · Cited by 10
Cortisol in metabolic syndrome
Mazgelytė, E., & Karčiauskaitė, D. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.06.008 · Cited by 18
NO-1886 ameliorates glycogen metabolism in insulin-resistant HepG2 cells by GSK-3β signalling
Wang, Z.-B., Zeng, H., Han-song, W., Yi, G., Yu, J., Wang, Y.-T., Zhang, Y., & Yin, W. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01402.x · Cited by 9
“A number of studies have shown deleterious effects of FFAs, such as promotion of triglyceride accumulation,([2]) activation of pro-inflammatory responses([2]) and protein kinase C,([3]) and impairment of glucose metabolism.([4]) Glucose homoeostasis depends on insulin responsiveness in target tissues, especially muscl…”
BackgroundLee, S., Kim, J. R., Ha, M., Shim, S., & Park, T. (2013) · Lipids · doi:10.1007/s11745-013-3766-6 · Cited by 9
Liu, F., Wang, S., Guo, X., Ye, Z.-X., Zhang, H., & Li, Z. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i6.632 · Cited by 8
Yang, C., Lu, H., Li, E., Oladele, P. O., & Ajuwon, K. M. (2022) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13698 · Cited by 8
Saka, S. O., Salisu, Y. Y., Sahabi, H. M., et al. (2023) · Molecules · doi:10.3390/molecules28020532 · Cited by 8
“Most obese individuals have elevated plasma levels of FFA and TG which are known to cause peripheral IR [10,78].”
BackgroundSourianarayanane, A., Brydges, C. R., & McCullough, A. J. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102402 · Cited by 9
TRPA1-Related Diseases and Applications of Nanotherapy
Yang, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179234 · Cited by 10
“Weight gain increases free fatty acid concentration, ultimately disrupting glucose homeostasis and causing insulin resistance in various tissues, leading to the development of T2DM [74].”
BackgroundMoriyama, K., Masuda, Y., Suzuki, N., Yamada, C., Kishimoto, N., Takashimizu, S., Akira, K. U. B. O., & Nishizaki, Y. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00958-1 · Cited by 9
“Previous epidemiologic studies have suggested that individuals with higher plasma concentrations of free fatty acids (FAs) are at increased risk of type 2 diabetes [1–3], and they have also been linked to peripheral (muscle) insulin resistance (IR) [4].”
BackgroundMartín‐Saladich, Q., Simó, R., Aguadé‐Bruix, S., Simó‐Servat, O., Aparicio, C., Hernández, C., Ramírez, C., Pizzi, M. N., Roque, A., Ballester, M. Á. G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043250 · Cited by 8
“, impaired insulin sensibility (IS) [4].”
Reno-protection of G004, a novel anti-diabetic sulfonylurea in db/db mice
Tong, X., Ma, H., Amadi, S. W., Ma, L., & Wu, G. (2015) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-015-1112-7 · Cited by 8
Acyclovir alleviates insulin resistance via activating PKM1 in diabetic mice
Hu, Z., Zhou, J., Han, L., Li, X., Li, C., Wu, T., Liu, J., Zhao, W., Kang, J., & Chen, X. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120725 · Cited by 7
Lipid composition of some commonly consumed traditional Nigerian dishes
Onabanjo, O. O., Sanni, S. A., Afolabi, W. A. O., Oyawoye, O. O., & Obanla, O. O. (2013) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12157 · Cited by 7
Natural Products Modulating Autophagy Pathway Against the Pathogenesis of Diabetes Mellitus
Li, L., Qi, J., & Li, H. (2018) · Current Drug Targets · doi:10.2174/1389450119666180726115805 · Cited by 8
Zheng, X., Zhu, J., Haedi, A. R., & Zhou, M. (2024) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2024.106908 · Cited by 6
Han, Q., Cao, Y., Gathaiya, N. W., Kemp, B. J., & Jensen, M. D. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00284.2017 · Cited by 6
Kcnma1 is involved in mitochondrial homeostasis in diabetes‐related skeletal muscle atrophy
Gao, S., Liu, Y., Wen, R., Huang, X., Li, P., Yang, Y., Yang, N., & Zhang, T. (2023) · The FASEB Journal · doi:10.1096/fj.202201397rr · Cited by 6
Resistin-binding peptide antagonizes role of resistin on white adipose tissue
Nan, G. U., Han, S., Li, F., Xiao-qin, P., Guo, M., Rong-hua, C. H. E. N., & Guo, X. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00480.x · Cited by 6
Panda, V. S., Shah, T., & Sudhamani, S. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2019-0139 · Cited by 6
“Free fatty acids (FFA) reduce insulin sensitivity in muscle by inhibiting insulin-mediated glucose uptake and glycogen synthesis (Boden 2003).”
BackgroundHeutling, D., Schulz, H., Randeva, H. S., Dodt, C., & Lehnert, H. (2007) · Der Internist · doi:10.1007/s00108-006-1776-7 · Cited by 7
Rimonabant may induce atrial fibrillation
Cocco, G., & Chu, D. (2009) · BMJ · doi:10.1136/bmj.b1061 · Cited by 6
Lipotoxicité et insulinorésistance
Magnan, C. (2006) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2006.04.006 · Cited by 6
Naomi, R., Teoh, S. H., Rusli, R. N. M., Embong, H., Bahari, H., & Kumar, J. (2023) · Nutrients · doi:10.3390/nu15102312 · Cited by 5
“Free fatty acids also impede the inhibition of insulin-modulated glycogenolysis, which results in insulin resistance [46].”
BackgroundLuo, H., & Zhu, Z. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1217237 · Cited by 5
Pham, T., Schelling, R. E., & Loh, K. H. (2025) · Advances in genetics · doi:10.1016/bs.adgen.2025.02.001 · Cited by 5
Pharmacology of signaling pathways: In type 2 diabetes
Meerza, D., Naseem, I., & Ahmed, J. (2013) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2013.06.006 · Cited by 5
Examining the association between serum free fatty acids and blood levels of testosterone
Kao, C.-C., Yang, Z., Cheng, Y. ‐., & Chen, W. (2020) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12828 · Cited by 5
Antioxidants: Pharmacothearapeutic Boon for Diabetes
Suresh, V., Reddy, A., Muthukumar, P., & Selvam, T. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98587 · Cited by 7
Lakshman, N. G., Rubavathy, S. M. E., Priyankha, S., et al. (2023) · New Journal of Chemistry · doi:10.1039/d3nj01068f · Cited by 5
Hasan, M. S., Das, N., Mahmud, Z. A., et al. (2016) · Advances in Pharmacological Sciences · doi:10.1155/2016/3040724 · Cited by 5
“Elevated plasma levels of free fatty acids (FFAs) are known to cause peripheral (muscle) insulin resistance [40] by inhibiting insulin-stimulated glucose uptake and glycogen synthesis.”
BackgroundSarkar, S., Anokye‐Danso, F., Tronieri, J. S., Millar, J. S., Alamuddin, N., Wadden, T. A., & Ahima, R. S. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04062-5 · Cited by 5
Yang, T., Zhao, B., & Pei, D. (2022) · Endocrine · doi:10.1007/s12020-021-02961-1 · Cited by 5
Park, M. J., Jung, S. R., Jung, H. L., Craig, B. W., Lee, C., & Kang, H. Y. (2008) · Yonsei Medical Journal · doi:10.3349/ymj.2008.49.6.1008 · Cited by 5
Zhang, H., Gan, M., Wu, Q., Dan, H., Chen, L., Niu, L., Zhao, Y., Wang, Y., Zhu, L., & Shen, L. (2025) · Food Chemistry X · doi:10.1016/j.fochx.2025.103211 · Cited by 5
Microbiota and Glucidic Metabolism: A Link with Multiple Aspects and Perspectives
Ciarambino, T., Crispino, P., Leto, G., Minervini, G., Para, O., & Giordano, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210409 · Cited by 4
“However, chronically elevated levels of FFAs inhibit glucose-stimulated insulin secretion and lead to beta-cell dysfunction by activating specific signaling pathways involved in glucose metabolism, insulin resistance, and beta-cell function [40] through cytotoxic mechanisms, causing beta-cell apoptosis [41,42].”
BackgroundFu, T.-D., Zhang, W., Zhang, Y., et al. (2024) · Natural Product Communications · doi:10.1177/1934578x231224993 · Cited by 4
Hosseini, A., Shafiee-Nick, R., Behzad, N. P. A., et al. (2012) · PubMed · Cited by 4
Chiba, I., Lee, S., Bae, S., Makino, K., Shinkai, Y., & Shimada, H. (2021) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14131 · Cited by 4
Jain, N., Patel, B. B., Hanawal, M. K., Lila, A. R., Memon, S. S., Bandgar, T., & Kumar, A. (2023) · Metabolomics · doi:10.1007/s11306-023-02066-y · Cited by 4
“More insulin availability makes up for the insulin resistance and can act as one of the factors for some obese people not developing diabetes (Boden, 2003).”
BackgroundManagement of Hypertension in Patients With Polycystic Ovarian Syndrome: A Mini-Review
Liaghatdar, A., Mazaheri‐Tehrani, S., & Fakhrolmobasheri, M. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000635 · Cited by 4
Arachidonic acid and glucose uptake by freshly isolated human adipocytes
Malipa, A. C. A., Meintjes, R. A., & Haag, M. (2007) · Cell Biochemistry and Function · doi:10.1002/cbf.1439 · Cited by 4
Rypka, M., Červenková, K., Uherková, L., Poczatková, H., Bogdanová, K., & Veselý, J. (2005) · Biomedical Papers · doi:10.5507/bp.2005.034 · Cited by 4
Wang, S., Lin, T., Wang, C.-H., Liu, H.-H., & Houng, J. (2012) · Mediators of Inflammation · doi:10.1155/2012/690525 · Cited by 4
“Furthermore, raised free fatty acids and TG in obese individuals and animals can be important etiologies of insulin resistance [46].”
BackgroundChang, C. W.-J., Kangath, A., Burton‐Freeman, B. M., Jackson, L. S., & Edirisinghe, I. (2014) · International Journal of Food Science Nutrition and Dietetics · doi:10.19070/2326-3350-1400020 · Cited by 4
“[1, 2] Oxidative stress and inflammation play a significant role in the etiology of endothelial dysfunction [3].”
Backgroundvan Berckel, M. M. G., van Loon, S. L. M., Boer, A.-K., Scharnhorst, V., & Nienhuijs, S. W. (2021) · Obesity Facts · doi:10.1159/000510401 · Cited by 4
Consequences and comorbidities associated with obesity
Ghouri, N., Clifton, P. M., Craigie, A. M., Anderson, A. S., Christensen, P., Waters, L., Williams, C., Coco, G. L., & Ricciardelli, L. A. (2017) · Wiley eBooks · doi:10.1002/9781118857991.ch2 · Cited by 4
Prenatal Risk Factors and Neurodevelopment
Shuffrey, L. C., & Fifer, W. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.23054-x · Cited by 5
Free fatty acids inhibit an ion-coupled membrane transporter by dissipating the ion gradient
Wang, X., Rusinova, R., Gregorio, G. G., & Boudker, O. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107955 · Cited by 3
Unger, J., Hinnen, D., Schreiner, B., & Parkin, C. (2012) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2012.00736.x · Cited by 3
“Elevated plasma FFA levels stimulate hepatic glucose production and impair insulin-stimulated glucose uptake in muscles and inhibit insulin secretion (Boden, 1999, 2003; Boden & Shulman, 2002).”
BackgroundHao, Y., Qu, L., Guo, Y., Ma, L., Guo, M., Zhu, Y., Jin, Y., Gu, Q., Zhang, Y., & Sun, W. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-05059-2 · Cited by 3
“Existing mechanistic studies also confirmed that the increase in serum FFAs can cause lipotoxicity through endoplasmic reticulum stress [25], reactive oxygen species [26], apoptosis, and inflammatory response [27], which leads to insulin resistance [28, 29].”
BackgroundSon, W.-H., Ha, M., & Park, T. (2024) · Physical Activity and Nutrition · doi:10.20463/pan.2024.0009 · Cited by 3
“Therefore, elevated plasma FFA contribute to metabolic dysregulation and insulin resistance (IR) 9,10 .”
BackgroundMu, J., Wang, X., Wang, Q., Cheng, F., Zhu, W., Li, C., Ma, C., Zhai, C., Lian, Y., & Du, X. (2019) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2019.08.001 · Cited by 3
Takahashi, N., Sasaki, A., Umemura, A., Sugai, T., Kakisaka, K., & Ishigaki, Y. (2022) · Biomedicines · doi:10.3390/biomedicines10112920 · Cited by 3
“High levels of serum FFA are associated with insulin resistance through the inhibition of insulin-stimulated glucose uptake and glycogen synthesis [27].”
BackgroundJensen, C., Storgaard, H., Holst, J., Dela, F., Madsbad, S., & Vaag, A. (2005) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2005.05.005 · Cited by 3
“[16,17]).”
Abadi, S. E. M., Balouchzadeh, R., Uzun, G., Ko, H. S., Lee, H. F., Park, S., & Kwon, G. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03251 · Cited by 3
“This is an open access ar nutrient overload, and alterations in cellular processes such as mitochondrial dysfunction and endoplasmic reticulum stress in β-cells and other tissues [7, 8, 9, 10].”
BackgroundPathophysiology of Insulin Action in Humans
Prato, S. D. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50011-5 · Cited by 3
Roohi, T. F., Parray, Z. A., Faizan, S., Solanki, D., Baig, M., Mehdi, S., & Kinattingal, N. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.153221 · Cited by 2
The Lipotoxicity and Glucotoxicity Hypothesis in the Metabolic Syndrome and Type 2 Diabetes
Dimitriadis, G., Boutati, E. I., & Raptis, S. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50016-4 · Cited by 2
Osawa, H., Yamada, K., Tabara, Y., Ochi, M., Onuma, H., Nishida, W., Shimizu, I., Kawamoto, R., Fujii, Y., Miki, T., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03143.x · Cited by 2
Das polyzystische Ovarsyndrom: Prototyp eines kardiometabolischen Syndroms
Heutling, D., Schulz, H., Randeva, H. S., Dodt, C., & Lehnert, H. (2007) · Der Internist · Cited by 2
Lusby, A. L. (2009) · Cited by 2
Sourianarayanane, A., Brydges, C. R., & McCullough, A. J. (2025) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.70069 · Cited by 1
Constantinopoulos, P., Georgoulia, G., Theofanis, G., Antzoulas, A., Litsas, D., Papadopoulos, P. D., Liolis, E., Leventis, P., Kornaros, N., Leivaditis, V., et al. (2025) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad/209847 · Cited by 1
“Furthermore, as has been demonstrated in other studies [48, 49], FFA can contribute to hepatic IR, and to systematic IR as well.”
Feng, Y., Song, Q., & Qin, Y. (2026) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2025.2610062 · Cited by 1
Capsaicin Improves Lipid Metabolism Disorders Caused by LPS-Induced Immune Stress in Weaned Piglets
Zhao, J., Liu, W., Zhang, X., Xie, Z., Liu, S., Zhou, W., & Zhang, L. (2026) · Veterinary Sciences · doi:10.3390/vetsci13020155 · Cited by 1
Zhang, W., Liu, G., Qu, X., Cong, D., & Liu, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1748699 · Cited by 1
Nonlinear Modeling of the Dynamic Effects of Free Fatty Acids on Insulin Sensitivity
Marmarelis, V. Z., Shin, D. C., & Mitsis, G. D. (2014) · Lecture notes in bioengineering · doi:10.1007/978-3-642-54464-4_10 · Cited by 1
Recabarren, S. E., Alejandro Lobos, L., Muñoz, P., Calvillán, M., & Parilo, J. (2005) · Archivos de medicina veterinaria · doi:10.4067/s0301-732x2005000200004 · Cited by 1
“…que podrían desencadenar la RI, fundamentalmente en el tejido muscular e hígado, actuando de manera similar a como lo hacen en la obesidad, ejerciendo su efecto sobre la actividad tirosina-kinasa del receptor de insulina, contribuyendo así a un estado de RI post-receptor (Boden 1996, Boden 2003).”
BackgroundDifferentially Expressed Proteins in the Pancreas of Diabetic Mice
Qiu, L. (2005) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Puberty, Insulin Resistance, and Type 2 Diabetes
Caprio, S., & Gower, B. A. (2005) · CRC Press eBooks · doi:10.1201/9781420026634.ch11 · Cited by 1
Harake, S. N. A., Abedin, Y., Hatoum, F., Nassar, N. Z., Ali, A., Nassar, A., Kanaan, A., Bazzi, S. I., Azar, S. T., Harb, F., et al. (2024) · Adipocyte · doi:10.1080/21623945.2024.2403380 · Cited by 1
“PLIN1 has been documented to activate This nuance is crucial, as it implies that insulin resistance would not necessarily lead to diabetes as long as NEFA-mediated insulin secretion is able to compensate for NEFA-induced insulin resistance [5,6].”
BackgroundInsulin resistance in major depressive disorder and the effects of psychotropic medications
Mason, J. S., Kenna, H. A., & Rasgon, N. (2012) · Clinical Practice · doi:10.2217/cpr.12.46 · Cited by 1
Bovolini, A., Garcia, J., Silva, A. F., Andrade, M. A., & Duarte, J. A. (2020) · Nutrition · doi:10.1016/j.nut.2020.110838 · Cited by 1
Role of Flame-Retardants as EDCs in Metabolic Disorders
Hussain, T., Yousaf, A. M., Ghori, M. U., et al. (2020) · Emerging contaminants and associated treatment technologies · doi:10.1007/978-3-030-45923-9_14 · Cited by 1
Scholle, L. M., Schieffers, H., Al‐Robaiy, S., Thaele, A., Urban, D. L., & Zierz, S. (2020) · Life · doi:10.3390/life10090204 · Cited by 1
“Elevated FFAs are discussed to be a major cause of insulin resistance in skeletal muscle and liver [18].”
BackgroundFatty Acids, Insulin Resistance and Diabetes
Juturu, V., & Gormley, J. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-330-1_18 · Cited by 1
Metabolic Syndrome, Diabetes and Nonalcoholic Steatohepatitis
Kyrou, I., Haukeland, J. W., Bhala, N. B., & Kumar, S. (2009) · Wiley eBooks · doi:10.1002/9781444307627.ch16 · Cited by 1
Type 2 diabetes: ceramides as a therapeutic target?
Hajduch, É., & Bourron, O. (2013) · Clinical Lipidology · doi:10.2217/clp.13.65 · Cited by 1
Exercise, muscle glycogen and insulin action
Johnstone, B. R. (2004) · Figshare
Ácidos graxos insaturados oléico e linoléico reprimem o gene Slc2a4 via NF-kB e SREBP-1.
Poletto, A. C. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2011.tde-19032012-131059
Nilsson, N. E. (2004) · Lund University Publications (Lund University)
Pathogenesis and Management of Obesity
Hoenig, M. E., & Rand, J. S. (2006) · Elsevier eBooks · doi:10.1016/b0-72-160423-4/50022-6
Xie, L. (2008) · K-State Research Exchange (Kansas State University)
Grygiel‐Górniak, B., McEneny, J., Linke, K., & Przysławski, J. (2010) · Polish Journal of Food and Nutrition Sciences
Metadata
- Authors
- Boden, G.
- Affiliations
- Temple University (US)
- Corresponding author
- Boden, G.
- Venue
- Experimental and Clinical Endocrinology & Diabetes
- Publisher
- Georg Thieme Verlag KG
- Published
- 2003-06-04
- Volume
- 111
- Issue
- 03
- Pages
- 121-124
- ISSN
- 0947-7349 (ISSN-L)
- 1439-3646
- OpenAlex
- W121967333
- Cited by
- 348
- References
- 0
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 20 · 2023: 17 · 2022: 26 · 2021: 30 · 2020: 17 · 2019: 17 · 2018: 15 · 2017: 16 · 2016: 9 · 2015: 12 · 2014: 14 · 2013: 13 · 2012: 18
- FWCI
- 14.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental and Clinical Endocrinology & Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag007988-10, 5r01ag015363-05)
- National Institute on Aging (AG15363, R01-AG07988)
- National Center for Research Resources (2 M01-RR-349)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- free fatty acids, insulin resistance, type 2 diabetes, glucose metabolism, skeletal muscle insulin signaling, hepatic insulin resistance, insulin secretion, diacylglycerol, protein kinase C, glycogen synthesis, glycogenolysis, obesity, NF-κB signaling, inflammation, coronary artery disease
- MeSH terms
- Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Glucose, Humans, Insulin Resistance, Liver, Obesity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review